Synovus Financial Corp Johnson & Johnson Transaction History

Synovus Financial Corp

$8.56 Billion
Q3 2024

A detailed history of Synovus Financial Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Synovus Financial Corp holds 241,246 shares of JNJ stock, worth $35.2 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

241,246

Previous 241,246 -0.0%

Holding current value

$35.2 Million

Previous $39.1 Million -0.0%

% of portfolio

0.46%

Previous 0.42%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $2.08 Million - $2.4 Million	-14,318 Reduced 5.6%	241,246 $39.1 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $1.17 Million - $1.27 Million	-8,077 Reduced 3.06%	255,564 $37.4 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $4.13 Million - $4.33 Million	-26,604 Reduced 9.17%	263,641 $41.7 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $581,570 - $651,508	-3,734 Reduced 1.27%	290,245 $45.2 Million
Q2 2023 Aug 08, 2023	BUY	$154.35 - $166.11 $119,621 - $128,735	775 Added 0.26%	293,979 $48.7 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $367,504 - $438,572	-2,433 Reduced 0.82%	293,204 $45.4 Million
Q4 2022 Feb 06, 2023	SELL	$160.2 - $179.79 $494,537 - $555,011	-3,087 Reduced 1.03%	295,637 $52.2 Million
Q3 2022 Oct 27, 2022	BUY	$161.33 - $179.52 $634,672 - $706,231	3,934 Added 1.33%	298,724 $48.8 Million
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $2.07 Million - $2.29 Million	12,312 Added 4.36%	294,790 $52.4 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $2.91 Million - $3.3 Million	-18,403 Reduced 6.12%	282,478 $50.1 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $687,339 - $762,628	4,408 Added 1.49%	300,881 $51.5 Million
Q3 2021 Nov 08, 2021	SELL	$161.5 - $179.47 $347,548 - $386,219	-2,152 Reduced 0.72%	296,473 $47.8 Million
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $550,684 - $590,704	-3,453 Reduced 1.14%	298,625 $49.1 Million
Q1 2021 May 11, 2021	BUY	$153.07 - $170.48 $444,209 - $494,732	2,902 Added 0.97%	302,078 $49.6 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $377,463 - $433,267	-2,753 Reduced 0.91%	299,176 $47.1 Million
Q3 2020 Nov 09, 2020	SELL	$140.38 - $153.83 $268,406 - $294,122	-1,912 Reduced 0.63%	301,929 $44.9 Million
Q2 2020 Aug 10, 2020	SELL	$128.81 - $155.51 $5.66 Million - $6.83 Million	-43,916 Reduced 12.63%	303,841 $42.7 Million
Q1 2020 Apr 24, 2020	BUY	$111.14 - $153.99 $5.02 Million - $6.95 Million	45,146 Added 14.92%	347,757 $45.7 Million
Q4 2019 Feb 06, 2020	SELL	$127.5 - $146.44 $662,490 - $760,902	-5,196 Reduced 1.69%	302,611 $44.1 Million
Q3 2019 Nov 01, 2019	BUY	$126.95 - $142.14 $426,044 - $477,021	3,356 Added 1.1%	307,807 $39.8 Million
Q2 2019 Aug 08, 2019	BUY	$131.15 - $144.24 $189,774 - $208,715	1,447 Added 0.48%	304,451 $42.4 Million
Q1 2019 May 09, 2019	BUY	$125.72 - $139.79 $235,725 - $262,106	1,875 Added 0.62%	303,004 $42.3 Million
Q4 2018 Feb 07, 2019	BUY	$122.84 - $147.84 $190,279 - $229,004	1,549 Added 0.52%	301,129 $38.9 Million
Q3 2018 Nov 01, 2018	BUY	$121.58 - $142.88 $272,947 - $320,765	2,245 Added 0.76%	299,580 $41.4 Million
Q2 2018 Aug 01, 2018	SELL	$119.4 - $131.76 $49,431 - $54,548	-414 Reduced 0.14%	297,335 $36.1 Million
Q1 2018 May 07, 2018	BUY	$125.1 - $148.14 $1.3 Million - $1.54 Million	10,403 Added 3.62%	297,749 $38.2 Million
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $8,529 - $9,335	65 Added 0.02%	287,346 $40.1 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $37.2 Million - $38.9 Million	287,281	287,281 $37.4 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Johnson & Johnson Transaction History